Fort Lauderdale, FL
RECO Immersive / Locations / Fort Lauderdale

Residential bipolar disorder treatment for Fort Lauderdale — observed adherence, real optimization.

A specialist outpatient program for clients in Fort Lauderdale. PHP, IOP, in-house psychiatry, sober-living network, family programming. Same admissions team, 24/7.

Start the conversation Or call directly — (561) 464-4077
26 mi from Fort Lauderdale
40 min average drive
24/7 admissions line
Why RECO Immersive from Fort Lauderdale

Local options exist. This is the clinical specialist.

For Fort Lauderdale clients, RECO Immersive's Delray Beach campus is a 40-minute drive up I-95 — close enough to keep family involved, far enough to break the environmental patterns tied to prior mood episodes. The program is built for the two-to-six-week window between acute stabilization and outpatient PHP: observed lithium, lamotrigine, or valproate titration; IPSRT-structured sleep-wake rhythm regulation; and family-focused therapy delivered in-person rather than by telehealth alone. Diagnosis is re-verified on admission using YMRS, PHQ-9, and the MDQ rather than accepting prior labels at face value.

From Las Olas, Victoria Park, or Coral Ridge, RECO Immersive’s Delray Beach campus sits roughly 26 miles north — a 40-minute I-95 drive that keeps Fort Lauderdale clients close to home without keeping them inside the environment where their last mood episode unfolded. For adults with bipolar I, bipolar II, or bipolar spectrum presentations, that geographic buffer matters: residential care works best when the client has genuine separation from the trigger stack of familiar spaces, sleep-disrupting routines, and interpersonal patterns tied to prior manic or depressive episodes. Immersive provides 24-hour clinical structure specifically for the stabilization window that outpatient PHP and IOP cannot reliably hold.

Residential bipolar treatment versus acute inpatient care

Acute mania with psychotic features, suicidal intent, or the inability to maintain basic safety belongs in locked inpatient care — Immersive is explicitly not that setting. Residential treatment for bipolar disorder becomes appropriate after acute stabilization, when the client is no longer at imminent risk but is still too fragile for the six or twelve clinical hours a day that PHP and IOP provide. That transitional window — typically two to six weeks after hospital discharge or after a severe outpatient decompensation — is the exact window outpatient care struggles to hold, and it is the window residential care exists to fill.

The other admission profile is severe bipolar depression that has not required hospitalization but has resisted outpatient treatment: clients with recurrent depressive episodes despite adequate trials of quetiapine, lurasidone, or lamotrigine; clients whose bipolarity was misdiagnosed as unipolar depression and treated with SSRI monotherapy for years; clients whose adherence has fractured across three or four outpatient prescribers. Residential-density care allows the treatment team to observe the actual trajectory of a medication trial rather than reconstruct it from a 20-minute follow-up appointment.

Mood stabilizer optimization under observed adherence

Lithium remains a first-line agent for bipolar I with the strongest anti-suicide evidence of any psychiatric medication, but it demands baseline TSH, creatinine, and pregnancy testing, careful titration to a maintenance serum level of 0.6–1.0 mEq/L, and ongoing monitoring for weight gain, thyroid suppression, and renal function. Lamotrigine — the mood stabilizer with the best evidence for bipolar depression — requires slow titration (25 mg daily for two weeks, 50 mg for two weeks, then stepping to 200 mg) specifically because rapid titration increases the risk of Stevens–Johnson syndrome. Valproate requires liver function tests, platelets, and serum levels titrated toward 50–125 mcg/mL, along with pregnancy counseling for reproductive-age patients.

In outpatient care, adherence commonly falters between weeks two and four of a titration — the window where side effects emerge but therapeutic effect has not. In residential, medication is observed, side effects are surfaced the same day they appear, and the treatment team can adjust dose, timing, or adjunctive agents (aripiprazole, quetiapine, or olanzapine for augmentation; buspirone or hydroxyzine for adjunctive anxiety) without losing the trial. For Fort Lauderdale clients who have abandoned three prior medication attempts in the outpatient setting, observed adherence is often the differentiator between a medication that works and a medication written off as ineffective.

Sleep-wake regulation and social rhythm therapy

Sleep disruption is both a symptom of bipolar mood episodes and a well-established trigger for them; a single night of significantly reduced sleep can precipitate a manic switch in vulnerable patients. Interpersonal and Social Rhythm Therapy (IPSRT), developed by Ellen Frank and colleagues, has the strongest evidence base of any bipolar-specific psychotherapy and treats sleep-wake regularity, meal timing, and social routine as clinical variables — not lifestyle recommendations.

Residential structure operationalizes IPSRT by design. Wake time is consistent. Sleep window is consistent. Meals occur at predictable intervals. Physical activity, group programming, and one-to-one sessions are anchored in a stable daily rhythm. Clients complete a Social Rhythm Metric daily and, over the course of admission, watch the correlation between rhythm regularity and mood variability emerge in their own data. They leave with the rhythm established rather than trying to build it from scratch in a Wilton Manors apartment where sleep has been broken for months.

Family-focused therapy and psychoeducation

Family-focused therapy (FFT) for bipolar disorder, developed at UCLA, has robust evidence for reducing relapse and rehospitalization when integrated with medication management. FFT targets three domains: psychoeducation about the illness and its warning signs, communication training, and structured problem-solving. High expressed emotion — critical or emotionally overinvolved family communication — is one of the more consistent psychosocial predictors of bipolar relapse in the research literature, and FFT was designed specifically to address it.

For Fort Lauderdale families, the 40-minute drive up I-95 makes in-person family sessions logistically feasible in a way that longer-distance admissions do not. Sessions cover episode warning signs specific to the client (irritability patterns, sleep changes, goal-directed activity), medication considerations (why lamotrigine cannot be stopped and restarted casually, why antidepressant monotherapy is contraindicated), and communication patterns that predict relapse. Where family cannot travel, sessions run via secure telehealth. The evidence supports treating bipolar disorder as a system-level illness, and family involvement is treated as core, not optional.

What to expect in the first week

Admission begins with a comprehensive psychiatric evaluation that formally re-diagnoses rather than accepting prior labels at face value: many clients presenting for “treatment-resistant depression” meet criteria for bipolar II on structured assessment. Baseline instruments typically include the PHQ-9 and GAD-7, the Young Mania Rating Scale (YMRS), the Mood Disorder Questionnaire (MDQ), and the ASRS when adult ADHD is on the differential. Substance use is screened against the ASAM Criteria dimensions; if alcohol or benzodiazepine dependence is present, CIWA or COWS monitoring begins on day one.

Baseline labs — CBC, comprehensive metabolic panel, TSH, lipid panel, HbA1c, pregnancy testing where applicable, and a urine drug screen — inform medication choices before titration begins. A treatment plan is developed within 72 hours and revisited weekly. Individual therapy draws on CBT, DBT, and ACT skills adapted for bipolar-specific targets (mood monitoring, prodrome recognition, impulsivity regulation); group programming includes IPSRT, psychoeducation, and process work. More detail on the clinical week is available on the residential bipolar treatment program page.

Insurance and admissions from Fort Lauderdale

RECO Immersive works with most major commercial plans held by Broward County residents, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Admissions staff run a verification of benefits before arrival so families understand deductible status, coinsurance, and authorized length of stay in concrete numbers rather than estimates. Same-day or next-day admission from Fort Lauderdale is often possible when the clinical picture supports residential level of care under ASAM or medical-necessity criteria and a bed is available.

Serving residents of: Las Olas, Victoria Park, Coral Ridge, Rio Vista, Wilton Manors.

Common questions

From Fort Lauderdale callers, most asked.

Does RECO Immersive accept my insurance from Fort Lauderdale?
RECO Immersive is in-network or accepts out-of-network benefits with most major commercial plans held by Fort Lauderdale and Broward County residents, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Admissions staff verify benefits before arrival and quantify expected out-of-pocket cost — deductible status, coinsurance percentage, and authorized length of stay — in concrete numbers, not estimates. Residential level of care generally requires medical-necessity documentation under ASAM criteria; the intake team handles that clinical documentation directly with the insurer. For self-pay and single-case-agreement inquiries, admissions can walk through the fee structure by phone before any commitment is made.
How long is residential bipolar treatment?
Length of stay is clinically determined, not fixed. Typical admissions run 21 to 45 days depending on presentation: shorter for medication optimization in an otherwise stable client, longer for severe bipolar depression, complex co-occurring substance use, or a history of multiple failed outpatient trials. The treatment team reassesses stay length weekly using the YMRS, PHQ-9, and sleep-rhythm data, and transitions the client to PHP when mood variability, sleep regularity, and medication tolerability have stabilized. Insurance authorization is renegotiated at each interval; length of stay is not artificially capped by the initial authorization window.
What happens on the first day of admission?
Day one is primarily assessment. A psychiatrist completes a full evaluation that formally re-diagnoses rather than accepting prior labels at face value, using structured instruments including the Young Mania Rating Scale, PHQ-9, GAD-7, and Mood Disorder Questionnaire. Baseline labs — CBC, comprehensive metabolic panel, TSH, lipid panel, HbA1c, and pregnancy testing where applicable — inform medication decisions before any titration begins. If alcohol or benzodiazepine dependence is present, CIWA or COWS monitoring is initiated the same day. A treatment plan is developed within 72 hours and reviewed weekly with the client.
Which mood stabilizer will I be started on?
Medication choice depends on the phase of illness, prior treatment history, and comorbidity. Lithium remains a first-line agent for bipolar I with the strongest anti-suicide evidence, but it requires baseline TSH and creatinine and careful titration to a serum level of 0.6–1.0 mEq/L. Lamotrigine has the best evidence for bipolar depression and requires slow titration to 200 mg over roughly six weeks to minimize Stevens–Johnson syndrome risk. Quetiapine, lurasidone, and cariprazine are FDA-approved for bipolar depression and are commonly used for augmentation. Valproate is favored for mixed features or rapid cycling but is generally avoided in reproductive-age women without contraceptive planning. Decisions are made jointly with the client rather than imposed.
How do I get to RECO Immersive from Fort Lauderdale?
RECO Immersive's residential campus is in Delray Beach, roughly 26 miles north of Fort Lauderdale — a 40-minute drive up I-95 in typical traffic. From Las Olas or Victoria Park, take I-95 North to Atlantic Avenue; from Coral Ridge, Rio Vista, or Wilton Manors, Federal Highway (US-1) is a slower but scenic alternative. The admissions team can arrange transportation from Fort Lauderdale for clients who cannot drive themselves or should not be driving given current mood state. For family visiting during the stay, the 40-minute drive is short enough to support meaningful in-person family therapy sessions rather than telehealth-only involvement.
How is my family involved, and how is my privacy protected?
Family-focused therapy has robust evidence for reducing bipolar relapse, and family sessions are integrated into the residential stay wherever the client consents. For Fort Lauderdale families, the 40-minute drive up I-95 makes in-person sessions practical. Sessions cover episode warning signs, medication considerations, and communication patterns — including the expressed-emotion research that identifies critical or overinvolved family dynamics as relapse predictors. All disclosures to family are governed by written releases; nothing is shared without the client's explicit authorization. Confidentiality is protected under HIPAA and, when substance use co-occurs, by the additional protections of 42 CFR Part 2.
Start admissions

Confidential. No commitment.

Tell us a little and a real human from admissions will call you back. We verify insurance benefits within minutes and tell you honestly whether RECO Immersive is the right fit — including if we should refer you elsewhere.

Carriers commonly used in Fort Lauderdale:
Florida Blue Aetna Cigna UnitedHealthcare Humana BCBS
Take the next step

When you’re ready, we’re here.

(561) 464-4077
Start AdmissionsSend a Message